Kala Pharmaceuticals Inc. buy me8
Start price
28.12.22
/
0%
€32.60
Target price
28.12.23
€40.00
Performance (%)
50.15%
End price
02.01.23
€48.95
Summary
This prediction ended on 02.01.23 with a price of €48.95. With a performance of 50.15% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | 9.266% | 9.266% | -92.056% | -96.690% |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% | 64.548% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% | 110.363% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% | 55.210% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% | 70.174% |
Comments by me8 for this prediction
In the thread Kala Pharmaceuticals Inc. diskutieren
Buy Kala Pharmaceuticals Inc.
Kursziel gesetzt auf 40,0